Encompass Health Corporation $EHC Shares Acquired by Hsbc Holdings PLC

Hsbc Holdings PLC boosted its position in Encompass Health Corporation (NYSE:EHC) by 37.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 379,586 shares of the company’s stock after buying an additional 103,392 shares during the period. Hsbc Holdings PLC’s holdings in Encompass Health were worth $36,481,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of EHC. WPG Advisers LLC increased its stake in shares of Encompass Health by 73.3% in the fourth quarter. WPG Advisers LLC now owns 324 shares of the company’s stock worth $34,000 after acquiring an additional 137 shares during the period. Flagship Harbor Advisors LLC purchased a new stake in Encompass Health in the fourth quarter valued at $37,000. Caitong International Asset Management Co. Ltd grew its position in Encompass Health by 36,200.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after purchasing an additional 362 shares during the period. Aster Capital Management DIFC Ltd purchased a new position in shares of Encompass Health during the 4th quarter valued at about $55,000. Finally, Covestor Ltd lifted its holdings in shares of Encompass Health by 24.4% in the 4th quarter. Covestor Ltd now owns 540 shares of the company’s stock valued at $57,000 after buying an additional 106 shares during the period. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Patrick William Tuer sold 682 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $104.56, for a total transaction of $71,309.92. Following the completion of the sale, the executive vice president owned 24,755 shares in the company, valued at $2,588,382.80. This trade represents a 2.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.80% of the stock is owned by corporate insiders.

Encompass Health Stock Performance

NYSE EHC opened at $112.40 on Tuesday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. The stock’s fifty day moving average is $104.62 and its two-hundred day moving average is $103.63. The firm has a market capitalization of $11.15 billion, a P/E ratio of 18.76, a price-to-earnings-growth ratio of 2.45 and a beta of 0.74. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.51 by $0.09. The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The company’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same period last year, the company earned $1.37 EPS. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, research analysts anticipate that Encompass Health Corporation will post 5.97 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st were paid a $0.19 dividend. The ex-dividend date of this dividend was Wednesday, July 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is 12.69%.

Analyst Upgrades and Downgrades

Several analysts recently commented on EHC shares. TD Cowen initiated coverage on Encompass Health in a report on Thursday, May 28th. They set a “buy” rating and a $125.00 target price on the stock. Barclays reduced their price target on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, May 5th. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Weiss Ratings cut shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, June 26th. Finally, Leerink Partners set a $152.00 price target on shares of Encompass Health in a research report on Friday, May 22nd. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $143.86.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.